Chlamydia / N. Gonorrhoeae RNA, TMA - Urine Collection Test Code: 11363 Includes: Chlamydia trachomatis, Neisseria gonorrhoeae Methodology: Dual Kinetic Assay (DKA) • Target Capture • Transcription-Mediated Amplification (TM)
2021 ICD-10-CM Diagnosis Code C49.A0 Gastrointestinal stromal tumor, unspecified site 2017 - New Code 2018 2019 2020 2021 Billable/Specific Code C49.A0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
M31.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM M31.1 became effective on October 1, 2019. This is the American ICD-10-CM version of M31.1 - other international versions of ICD-10 M31.1 may differ.
M31.1 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. ICD-10-CM M31.1 is a new 2022 ICD-10-CM code that became effective on October 1, 2021. This is the American ICD-10-CM version of M31.1 - other international versions of ICD-10 M31.1 may differ.
Overview. Chlamydia (kluh-MID-e-uh) trachomatis (truh-KOH-muh-tis) is a common sexually transmitted infection (STI) caused by bacteria.
ICD-10 code Z11. 3 for Encounter for screening for infections with a predominantly sexual mode of transmission is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Encounter for screening for infections with a predominantly sexual mode of transmission. Z11. 3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
ICD-10 code A74. 9 for Chlamydial infection, unspecified is a medical classification as listed by WHO under the range - Certain infectious and parasitic diseases .
STD screening requested by patient Use diagnosis code V01. 6 for “contact with or exposure to a venereal disease.” Codes V73. 88 (screening for chlamydial disease) and V74. 5 (screening for venereal disease) may be reported based on risk factors.
Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) are the two most common bacterial causes of sexually transmitted diseases worldwide. In the United States CT and GC account for about 4 million and 2 million annual cases of genital infection respectively.
Z00.00ICD-10 Code for Encounter for general adult medical examination without abnormal findings- Z00. 00- Codify by AAPC.
A64 - Unspecified sexually transmitted disease. ICD-10-CM.
For claims for screening for syphilis in pregnant women at increased risk for STIs use the following ICD-10-CM diagnosis codes: • Z11. 3 - Encounter for screening for infections with a predominantly sexual mode of transmission; • and any of: Z72. 89 - Other problems related to lifestyle, or Z72.
A74. 9 - Chlamydial infection, unspecified. ICD-10-CM.
ICD-10-CM Diagnosis Code A56 A56. 00 Chlamydial infection of lower genitourinary t...
ICD-10 code N73. 9 for Female pelvic inflammatory disease, unspecified is a medical classification as listed by WHO under the range - Diseases of the genitourinary system .
Urine: Patient should not have urinated within one hour prior to collection. Female patients should not cleanse the labial area prior to providing the specimen.
1 vaginal swab in Aptima® Transport Tube or 1 endocervical or urethral swab in Aptima® Transport Tube or 2 mL urine in Aptima® Transport Tube or 1 mL liquid cytology (PreservCyt®) Preservative (ThinPrep®) in Aptima® Transfer Tube or 0.5 mL SurePath™ Preservative Fluid in Aptima® Transfer Tube
1 vaginal swab in Aptima® Transport • 1 endocervical or urethral swab in Aptima® Transport • 2 mL urine in Aptima® Transport • 1 mL PreservCyt® (ThinPrep®) in Aptima® Transfer Tube • 0.5 mL SurePath™ fluid in Aptima® Transfer Tube
Vaginal Swab: Follow instructions in the Aptima® Vaginal Swab Collection or Multitest Collection Kit (orange label).
Vaginal Swab: Follow instructions in the Aptima® Vaginal Swab Collection or Multitest Collection Kit (orange label).
Gastrointestinal stromal tumor, unspecified site 1 C49.A0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM C49.A0 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of C49.A0 - other international versions of ICD-10 C49.A0 may differ.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.